SCLDSCCL
ABBV icon

Split Creek LLC DBA Split Creek Capital LLC’s AbbVie ABBV Stock Holding History

Split Creek LLC DBA Split Creek Capital LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73M Hold
6,860
– – 1.59% 10
2026
Q1 		$1.49M Buy
6,860
+500
+8% +$111K 1.57% 11
2025
Q4 		$1.45M Buy
+6,360
New +$1.45M 1.54% 12

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Split Creek LLC DBA Split Creek Capital LLC's ABBV Position: Q2 2026 in Review

Split Creek LLC DBA Split Creek Capital LLC held its AbbVie (ABBV) position steady in Q2 2026 at 6,860 shares worth $1.73M. The position accounts for 1.59% of the portfolio, ranked #10.

Split Creek LLC DBA Split Creek Capital LLC first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,245 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Split Creek LLC DBA Split Creek Capital LLC held 6,860 shares of AbbVie worth $1.73M as of Q2 2026.
  • Split Creek LLC DBA Split Creek Capital LLC left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 1.59% of Split Creek LLC DBA Split Creek Capital LLC's portfolio in Q2 2026, its #10 holding.
  • Split Creek LLC DBA Split Creek Capital LLC first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,245 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Split Creek LLC DBA Split Creek Capital LLC's 13F filing for Q2 2026, filed 23 Oct 2026.